Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VON HOFF DD")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 62

  • Page / 3
Export

Selection :

  • and

PHARMACOKINETICS OF ICRF-187 IN THE CEREBROSPINAL FLUID OF SUBHUMAN PRIMATESVON HOFF DD.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 734-736; BIBL. 6 REF.Article

IN VITRO EVALUATION OF ANTICANCER DRUGS WITH THE HUMAN TUMOR STEM CELL ASSAYSALMON SE; VON HOFF DD.1981; SEMIN. ONCOL.; ISSN 0093-7754; USA; DA. 1981; VOL. 8; NO 4; PP. 377-385; BIBL. 24 REF.Article

CULTURE OF HUMAN HEAD AND NECK CANCER CELLS USING SOFT AGARMATTOX DE; VON HOFF DD.1980; ARCH. OTOLARYNGOL. (1960); ISSN 0003-9977; USA; DA. 1980; VOL. 106; NO 11; PP. 672-674; BIBL. 11 REF.Article

CIS-DIAMINEDICHLOROPLATINUM(II): A METAL COMPLEX WITH SIGNIFICANT ANTICANCER ACTIVITYVON HOFF DD; ROZENWEIG M.1979; ADV. PHARMACOL. CHEMOTHERAPY; USA; DA. 1979; VOL. 16; PP. 273-298; BIBL. 5 REF.Article

5-AZACYTIDINE: A NEW ANTICANCER DRUG WITH SIGNIFICANT ACTIVITY IN ACUTE MYELOBLASTIC LEUKEMIA.VON HOFF DD; SLAVIK M.1977; ADV. PHARMACOL. CHEMOTHERAPY; U.S.A.; DA. 1977; VOL. 14; NO 285-326; BIBL. 3 P. 1/2Article

DIAGNOSTIC RELIABILITY OF NEEDLE BIOPSY OF THE PARIETAL PLEURA. = FIABILITE DIAGNOSTIC DE LA BIOPSIE A L'AIGUILLE DE LA PLEVRE PARIETALEVON HOFF DD; LIVOLSI V.1975; AMER. J. CLIN. PATHOL.; U.S.A.; DA. 1975; VOL. 64; NO 2; PP. 200-203; BIBL. 14 REF.Article

INVESTIGATIONAL CHEMOTHERAPEUTIC AGENTS IN HEAD AND NECK CANCER.ROZENCWEIG M; VON HOFF DD; MUGGIA FM et al.1977; SEMINARS IN ONCOL.; U.S.A.; DA. 1977; VOL. 4; NO 4; PP. 425-429; BIBL. 1 P. 1/2Article

5-AZACYTIDINE. A NEW ANTICANCER DRUG WITH EFFECTIVENESS IN ACUTE MYELOGENOUS LEUKEMIA.VON HOFF DD; SLAVIK M; MUGGIA FM et al.1976; ANN. INTERN. MED.; U.S.A.; DA. 1976; VOL. 85; NO 2; PP. 237-245; BIBL. 1 P. 1/2Article

UPTAKE OF MELPHALAN BY HUMAN OVARIAN CARCINOMA CELLS AND RELATIONSHIP TO THE AMINO ACID CONTENT OF ASCITIC FLUIDVISTICA DT; VON HOFF DD; TORAIN B et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 1-2; PP. 157-161; BIBL. 18 REF.Article

CYTEMBENA: AN ANTICANCER DRUG WITH AN UNIQUE STRUCTURE.VON HOFF DD; ROZENCWEIG M; MUGGIA FM et al.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 26; NO 6; PP. 388-392; BIBL. 38 REF.Article

DOES COLOR OF AN ANTITUMOR AGENT PREDICT FOR CLINICAL ANTITUMOR ACTIVITY.VON HOFF DD; KUHN J; CLARK G et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 1; PP. 93-94; BIBL. 2 REF.Article

THE EVALUATION OF CYTOTOXIC DRUGSVON HOFF DD; ROZENCWEIG M; MUGGIA FM et al.1979; CANCER TREATM. REV.; GBR; DA. 1979; VOL. 6; SUPPL.; PP. 1-8; H.T. 1; BIBL. 13 REF.Conference Paper

DAUNOMYCIN: AN ANTHRACYCLINE ANTIBIOTIC EFFECTIVE IN ACUTE LEUKEMIA.VON HOFF DD; ROZENCWEIG M; SLAVIK M et al.1978; ADV. PHARMACOL. CHEMOTHERAPY; USA; DA. 1978; VOL. 15; PP. 1-50; BIBL. 5 P.Article

USE OF A HUMAN TUMOR CLONING SYSTEM TO SCREEN RETINOIDS FOR ANTINEOPLASTIC ACTIVITY = UTILISATION D'UN SYSTEME DE CLONAGE TUMORAL HUMAIN POUR SELECTIONNER LES RETINOIDES SELON LEUR ACTIVITE ANTICANCEREUSECOWAN JD; VON HOFF DD; DINESMAN A et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 1; PP. 92-96; ABS. ENG; BIBL. 42 REF.; GRAPHArticle

CC-1065 (NSC 298223), A MOST POTENT ANTITUMOR AGENT: KINETICS OF INHIBITION OF GROWTH, DNA SYNTHESIS, AND CELL SURVIVALBHUYAN BK; NEWELL KA; CRAMPTON SL et al.1982; CANCER RES.; USA; DA. 1982; VOL. 42; NO 9; PP. 3532-3537; BIBL. 12 REF.Article

METHODS FOR DETERMINING CHEMOSENSITIVITY OF MCF-7 CELLS IN DOUBLE-LAYER AGAR CULTURE: LABELING INDEX DEPRESSION AND COLONY COUNT INHIBITIONELSON DL; OSBORNE CK; LIVINGSTON RB et al.1982; STEM CELLS; ISSN 0250-6793; CHE; DA. 1982; VOL. 2; NO 1; PP. 34-44; BIBL. 14 REF.Article

ACTIVITY OF HUMAN LEUKOCYTE INTERFERON IN A HUMAN TUMOR CLONING SYSTEMVON HOFF DD; GUTTERMAN J; PORTNOY B et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 1; PP. 99-103; BIBL. 26 REF.Article

CLINICAL TRIALS WITH THE HEXITOL DERIVATIVES IN THE U.S.CHIUTEN DF; ROZENCWEIG M; VON HOFF DD et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 3; PP. 442-451; BIBL. 68 REF.Article

CLINICAL TRIALS WITH CIS-DIAMMINEDICHLOROPLATINUM (II) (DDP)HENNEY JE; ROZENCWEIG M; VON HOFF DD et al.1978; BIOCHIMIE; FRA; DA. 1978; VOL. 60; NO 9; PP. 931-934; BIBL. 12 REF.Conference Paper

ESTRAMUSTINE PHOSPHATE: A SPECIFIC CHEMOTHERAPEUTIC AGENT.VON HOFF DD; ROZENCWEIG M; SLAVIK M et al.1977; J. UROL.; U.S.A.; DA. 1977; VOL. 117; NO 4; PP. 464-466; BIBL. 17 REF.Article

TIME RELATIONSHIP BETWEEN LAST DOSE OF DAUNORUBICIN AND CONGESTIVE HEART FAILURE.VON HOFF DD; LAYARD M; ROZENCWEIG M et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 7; PP. 1411-1413; BIBL. 8 REF.Article

ACTIVITY OF 9-10 ANTHRACENEDICARBOXALDEHYDE BIS((4,5-DIHYDRO-1H-IMIDAZOL-2-YL) HYDRAZONE) DIHYDROCHLORIDE (CL216, 942) IN A HUMAN TUMOR CLONING SYSTEM LEADS FOR A PHASE II TRIALS IN MANVON HOFF DD; COLTMAN CA JR; FORSETH B et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 2; PP. 141-144; BIBL. 10 REF.Article

AZASERINE, DON, AND AZOTOMYCIN: THREE DIAZO ANALOGS OF L-GLUTAMINE WITH CLINICAL ANTITUMOR ACTIVITYCATANE R; VON HOFF DD; GLAUBIGER DL et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 6; PP. 1033-1038; BIBL. 35 REF.Article

THE EFFECT OF PREOPERATIVE ADRIAMYCIN AND DIHYDROXYANTHRACENEDIONE ON WOUND HEALINGMULLEN BM; MATTOX DE; VON HOFF DD et al.1981; LARYNGOSCOPE; ISSN 0023-852X; USA; DA. 1981; VOL. 91; NO 9; PART. 1; PP. 1436-1443; BIBL. 14 REF.Article

DIRECT CLONING OF HUMAN PARATHYROID HYPERPLASIA CELLS IN THE SOFT-AGAR CULTUREBRADLEY EC; REICHERT CM; BRENNAN MF et al.1980; CANCER RES.; ISSN 0008-5472; USA; DA. 1980; VOL. 40; NO 10; PP. 3694-3696; BIBL. 9 REF.Article

  • Page / 3